Advaxis, Inc. Gains 33.54%
Thu, Jan 30, 2020 at 05:30 PM
Advaxis, Inc. (ADXS:NASDAQ) rocketted at $0.9, a gain of 33.5%. On Wed 29 Jan 20, ADXS:NASDAQ hit a New 2-Week Low of $0.68. The stock got featured on our News Catalysts scanner on Thu 30 Jan 20 at 10:31 AM in the 'BIOTECH' category. From Wed 08 Jan 20, the stock recorded 28.57% Up Days and 26.67% Green Days
The stock spiked on Tue 07 Jan 20 at $1.48 with a volume of 39M+.
About Advaxis, Inc. (ADXS:NASDAQ)
Advaxis Inc focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies.
Top 10 Gainers:
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 41.26%
- Sintx Technologies, Inc. (SINT:NASDAQ), 41.1%
- Advaxis, Inc. (ADXS:NASDAQ), 33.54%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 29.65%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 27.56%
- NanoViricides, Inc. (NNVC:NYSEMKT), 26.58%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 20.87%
- Lianluo Smart Limited (LLIT:NASDAQ), 20.83%
- Miragen Therapeutics, Inc. (MGEN:NASDAQ), 20.71%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 20.4%